Re-think rescue Tx: Consider options to target pathophysiology.
| Publicado en: | Dermatology Times Vol. 41; no. 1; pp. 1 - 3 |
|---|---|
| Autor principal: | |
| Formato: | pictorial Journal Article |
| Publicado: |
MJH Life Sciences
Jan2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=141290069&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 141290069 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 01966197 DTI jtl: Dermatology Times issn: 01966197 maglogo: N pubinfo: dt: Jan2020 vid: 41 iid: 1 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 141290069 141290069 141290069 141290069 ppf: 1 ppct: 2 formats: tig: atl: Re-think rescue Tx: Consider options to target pathophysiology. aug: au: HILTON, LISETTE sug: subj: Dermatitis, Atopic Drug Therapy Dermatitis, Atopic Physiopathology Dermatologists Antibodies, Monoclonal Therapeutic Use Physician-Patient Relations Biological Products Therapeutic Use Immunosuppressive Agents Therapeutic Use Immunosuppressive Agents Adverse Effects Patient Safety Biological Products Adverse Effects pubtype: Trade Publication doctype: pictorial Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|